Tickers

BTU — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-23 06:56:13.411506 UTC · finished 2026-09-23 07:00:44.139949 UTC

1. Composite Trajectory Verdict

For a capital-intensive coal producer with significant reclamation obligations, the cash flow statement carries the most weight because it captures the cash costs of production, collateral dynamics, and debt service that determine solvency and shareholder return capacity.

Composite Trajectory: Deteriorating

The income statement shows a sharp swing from annual profit to loss and widening quarterly losses despite recent revenue growth. Cash generation has collapsed, with operating cash flow down 45% year-over-year for the full year 2025 and down 80% for the first six months of 2026. The balance sheet reflects rapid equity erosion, falling 8.1% in just six months, while restricted cash releases flatter liquidity metrics. All three statements point to deteriorating fundamentals in the most recent comparable periods.

2. Red Flags

  • GAAP net income swung from $403.5 million profit (FY2024) to -$42.5 million loss (FY2025) (10-K 2025-12-31, Consolidated Statements of Operations)
  • Six-month GAAP net loss attributable to common stockholders widened from $6.8 million profit (6M 2025) to -$123.0 million loss (6M 2026) (10-Q 2026-06-30, Consolidated Statements of Operations)
  • Operating cash flow fell 45% annually to $333.7 million (FY2025 vs FY2024 $606.5 million) and 80% for six months to $28.6 million (6M 2026 vs 6M 2025 $143.1 million) (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows)
  • Stockholders' equity declined 8.1% in six months to $3,248.6 million (Jun 2026) from $3,536.4 million (Dec 2025) (10-Q 2026-06-30, Consolidated Balance Sheets)
  • Restricted cash and collateral dropped $384.3 million in six months to $459.8 million (Jun 2026) from $844.1 million (Dec 2025), a one-time release from surety facility restructuring that masks operational cash burn (10-Q 2026-06-30, Consolidated Balance Sheets; Off-Balance-Sheet Arrangements)
  • Anglo arbitration claim quantified at $755.0 million in June 2026, with Peabody unable to estimate possible loss range (10-Q 2026-06-30, MD&A – Arbitration Relating to Terminated Anglo Acquisition)
  • Induced conversion expense of $17.2 million recognized in Q2 2026 from repurchasing 2028 Convertible Notes at a premium (10-Q 2026-06-30, MD&A – Induced Conversion Expense)
  • Working capital shifted from a $302.3 million source in FY2025 to a $95.1 million use in 6M 2026 (10-K 2025-12-31, Cash Flows; 10-Q 2026-06-30, Cash Flows)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: GAAP profitability has deteriorated sharply across all comparable periods. Full-year 2025 net loss attributable to common stockholders was -$52.9 million versus $370.9 million profit in 2024, with diluted EPS falling from $2.70 to -$0.43 (10-K 2025-12-31, Consolidated Statements of Operations). The six-month comparison shows a swing from $6.8 million profit (6M 2025) to -$123.0 million loss (6M 2026), with diluted EPS moving from $0.06 to -$1.01 (10-Q 2026-06-30, Consolidated Statements of Operations). Quarterly Q2 results worsened from -$27.6 million loss (Q2 2025) to -$90.6 million loss (Q2 2026). Revenue grew 8% in 6M 2026 to $1,976.5 million, but operating costs and expenses rose 16.6% to $1,818.6 million, compressing margins (10-Q 2026-06-30, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Overall Assessment: Operating cash generation has declined precipitously. FY2025 net cash from operating activities was $333.7 million, down 45% from $606.5 million in FY2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The first six months of 2026 generated only $28.6 million versus $143.1 million in 6M 2025, an 80% decline (10-Q 2026-06-30, Consolidated Statements of Cash Flows). The FY2025 decrease was driven by a $156.4 million year-over-year decrease in cash from collateral arrangements and $68.6 million in terminated acquisition costs, partially offset by a $302.3 million working capital benefit. In 6M 2026, working capital turned to a $95.1 million use, and lower mining cash generation was only partially offset by a $75.8 million collateral release (10-Q 2026-06-30, Cash Flows). Investing cash outflows remained elevated at -$184.1 million (6M 2026) versus -$180.7 million (6M 2025). Financing outflows surged to -$202.0 million (6M 2026) from -$44.9 million (6M 2025) due to $494.1 million in long-term debt repayments related to the convertible note restructuring (10-Q 2026-06-30, Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Overall Assessment: The balance sheet shows accelerating equity erosion and reliance on non-recurring collateral releases. Total stockholders' equity fell 3.1% year-over-year to $3,536.4 million (Dec 2025) from $3,650.5 million (Dec 2024) (10-K 2025-12-31, Consolidated Balance Sheets). In the subsequent six months, equity dropped another 8.1% to $3,248.6 million (Jun 2026) (10-Q 2026-06-30, Consolidated Balance Sheets). Restricted cash and collateral — a key liquidity buffer for reclamation bonding — fell 45.5% in six months to $459.8 million from $844.1 million, driven by the Australian surety bond facility replacement (10-Q 2026-06-30, Consolidated Balance Sheets; Off-Balance-Sheet Arrangements). Total debt remained relatively flat at $339.0 million (Jun 2026) versus $336.4 million (Dec 2025), but the 2028 Convertible Notes were reduced to $78.8 million from $320.0 million with new 2031 Convertible Notes of $250.0 million issued (10-Q 2026-06-30, Indebtedness). Asset retirement obligations were stable at ~$754 million. Available liquidity improved marginally to $959.1 million (Jun 2026) from $942.1 million (Dec 2025) due to increased revolver availability (10-Q 2026-06-30, Liquidity).

6. Data Gaps

  • Q1 2026 and Q1 2025 quarterly GAAP income statement details (10-Q 2026-03-31 not fully provided)
  • Q3 2025 and Q3 2024 quarterly GAAP results for seasonal trend analysis
  • June 30, 2025 balance sheet for year-over-year quarterly balance sheet comparison
  • Full-year 2026 results (only six months available)
  • Segment-level GAAP operating income (filings provide only non-GAAP Adjusted EBITDA by segment)
  • Detailed capital expenditure breakdown for 2026 beyond the $340 million target mentioned in 10-K
  • Reconciliation of non-GAAP Adjusted EBITDA to GAAP operating income by segment for quarterly periods
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status